Breakthrough Pain Clinical Trial
Official title:
Quality of Life Study in Patients With Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent
In the context of radiotherapy, control of breakthrough pain represents a special challenge.
Patients undergoing radiotherapy may experience different situations of pain that may be due
to the need to remain immobilized during radiotherapy session, the need to wear an
immobilization mask (head and neck cancer), the odynophagia caused by mucositis, defecation
after the development of proctitis, or sudden pain during the night causing sleep
disturbances.
In a survey conducted in radiation oncology services more than half of patients treated with
radiotherapy experienced pain, and 39% of patients reported that their pain was not treated
properly. This situation may increase the patient's anxiety, dissatisfaction with treatment,
affect their quality of life and can even come to refuse radiotherapy treatment.
This post-authorization observational study will assess the quality of life of cancer
patients with breakthrough cancer pain treated in radiotherapy services in Spanish hospitals.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00994760 -
Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years
|
N/A | |
| Completed |
NCT01842893 -
Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer
|
Phase 3 | |
| Completed |
NCT02886286 -
Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain
|
Phase 4 | |
| Completed |
NCT02869321 -
Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy
|
Phase 4 | |
| Completed |
NCT02840500 -
Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units
|
N/A | |
| Completed |
NCT02437929 -
Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment
|
N/A | |
| Completed |
NCT00236145 -
Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain
|
Phase 3 | |
| Active, not recruiting |
NCT02278601 -
Comparison of Regimens MPIB, CIPCEA, PCEA
|
Phase 3 | |
| Terminated |
NCT00842829 -
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
|
Phase 4 | |
| Recruiting |
NCT05200806 -
A Prospective Pilot Study of a Non-Narcotic Post-Operative Course After Colectomy
|
Phase 4 | |
| Withdrawn |
NCT03809455 -
Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
|
Phase 2 | |
| Completed |
NCT03435120 -
Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)
|
||
| Completed |
NCT02050503 -
Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis
|
N/A | |
| Terminated |
NCT00387010 -
Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
|
Phase 3 | |
| Withdrawn |
NCT05053308 -
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
|
N/A | |
| Recruiting |
NCT04011150 -
Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour
|
Phase 3 | |
| Terminated |
NCT01901718 -
An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.
|
N/A | |
| Completed |
NCT00402350 -
Staccato Fentanyl Single and Multidose PK
|
Phase 1 | |
| Completed |
NCT00236041 -
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
|
Phase 2 |